The Children’s Hospital Research Institute of Manitoba (CHRIM) is the research division of the Children’s Hospital Foundation of Manitoba.
At the Institute, more than 300 world-class pediatric medical researchers, technical staff, students, and support staff are involved in over $22 million of research and clinical trial activity each year.
CHRIM is the first research facility in the prairie provinces dedicated exclusively to pediatric research. CHRIM brings together top researchers from a variety of health disciplines who share a common goal of improving the health of children and youth. By including a wide range of disciplines, CHRIM has the unique ability to look at the overall picture of pediatric health – not just one area. The Institute fosters a collaborative and innovative research environment, offering hope to children and their families as researchers work towards medical breakthroughs and cures for childhood illness. Key areas of study at CHRIM include:
- Type 1 and Type 2 diabetes
- Pediatric cancer
- Mental health
- Therapeutic use of cannabinoids for complex diseases and conditions
- Respiratory challenges
- Developmental origins of health and disease (DOHaD)
- Vaccines for infectious diseases
- Nutrition and metabolism
- Obesity and physical activity
- Kidney disease
- Genetics
- Neurosciences
- Pharmacology
- Autism
- Emergency medicine
- Oral health
With over 100 research projects ongoing, contributions are needed to provide core funding for research projects, as well as infrastructure support for researchers. Your investment will help unlock the mysteries of childhood diseases to get our kids back to where they should be – being kids.
Donors to the Foundation provide $4 million in funding for CHRIM each year, which researchers leverage into more than $20 million in grants from prestigious groups like CIHR, NIH and Gates Foundation each year.
If funding goals are achieved, additional dollars will be allocated to the area of greatest need.
Stay in touch!
Sign up for e-news to get updates on the latest events, news, and stories.
sign up for the newsletter